Pain device maker NeuroMetrix settles FTC false advertising case

NATE RAYMOND | March 5, 2020

article image
Pain treatment device manufacturer NeuroMetrix and its founder will pay $4 million and turn over money earned through a collaboration with GlaxoSmithKline to resolve allegations it made false claims about its flagship product. The settlement with the U.S. Federal Trade Commission was disclosed in a filing on Tuesday in Boston federal court and resolves claims against NeuroMetrix and Shai Gozani, its chief executive, related to its Quell wearable pain treatment device.

Spotlight

DemandWorks Media

The days of mass broadcast, static content email newsletters are over, guessing which content readers might like to see and ‘hoping for a bite’ only results in poor conversion. Here at DemandWorks we’re passionate about delivering a fully personalized 1:1 email experience, gathering real-time data around preferences, technology, and research, and then acting on that data to drive superior engagement and enhanced conversion.

OTHER ARTICLES

Bored? Tampa Bay company’s app spices up sports reruns

Article | April 15, 2020

With live sports on hold for the foreseeable future, broadcasters have started reairing games from yesteryear to keep audiences entertained during the coronavirus pandemic. For sports fans who know the outcome, reruns can be dull. Enter Super Squares, an app developed by Tampa-based React LLC that can put the adrenaline back into those dusty classics. The iOS and Android app is a modern take on “football squares” players check in before a game and make predictions, answer questions about ads and the game at regular intervals, and earn new super squares.

Read More

Google updates its ads policy for inappropriate content to include ‘public health emergency’

Article | March 31, 2020

Amid the COVID-19 pandemic, Google Ads has updated its Inappropriate content policy. The updates take aim at keywords around sensitive events, price gouging and more. The update, released Tuesday and effective immediately, does not specifically mention coronavirus, but the change is clearly aimed at preventing advertisers from trying to capitalize on the outbreak. Google banned ads for face masks earlier this month. Why we care. Digital platforms have struggled to stay ahead of misinformation and fraudulent claims as well as price gauging by advertisers trying to take advantage of the coronavirus crisis. This policy update may appear subtle, but it gives Google a clearer path to take action against bad actors and prevent advertisers from advertising on coronavirus-related keywords during this pandemic.

Read More

Pain device maker NeuroMetrix settles FTC false advertising case

Article | March 5, 2020

Pain treatment device manufacturer NeuroMetrix and its founder will pay $4 million and turn over money earned through a collaboration with GlaxoSmithKline to resolve allegations it made false claims about its flagship product. The settlement with the U.S. Federal Trade Commission was disclosed in a filing on Tuesday in Boston federal court and resolves claims against NeuroMetrix and Shai Gozani, its chief executive, related to its Quell wearable pain treatment device.

Read More

YouTube Will Not Show Advertising on Videos About Coronavirus

Article | March 5, 2020

Coronavirus, which emerged in Wuhan, China, has become one of the most talked about topics in a short time. Especially on social media, many sharing and informing about Coronavirus was made. However, channels that prepare content related to Corona virus on YouTube will not be able to earn income from these videos due to the company policy. Last month, the YouTube channel Insider made a video about the Coronavirus. As of February 11, YouTube announced that it is treating the Coronavirus as a sensitive issue. All videos shot about the Corona virus on YouTube will not be able to receive ads until the next announcement, and therefore will not be able to earn revenue from these videos.

Read More

Spotlight

DemandWorks Media

The days of mass broadcast, static content email newsletters are over, guessing which content readers might like to see and ‘hoping for a bite’ only results in poor conversion. Here at DemandWorks we’re passionate about delivering a fully personalized 1:1 email experience, gathering real-time data around preferences, technology, and research, and then acting on that data to drive superior engagement and enhanced conversion.

Events